BOSTON, March 29, 2018 (GLOBE NEWSWIRE) -- Cambridge Healthtech Institute, a division of Cambridge Innovation Institute, is pleased to once again invite the community to join the knowledge-sharing and celebration of the annual Bio-IT World Conference & Expo, May 15-17, 2018 in Boston. Headlining the 2018 keynote sessions are esteemed data scientists from across the life science industry: Liberty BioSecurity’s Mark Boguski, TCB Analytics’ Tanya Cashorali, Alexion Pharmaceuticals’ John Reynders, Merck’s veteran Jerald Schindler, and H3 Biomedicine’s Lihua Yu. Together they will assess today’s most impactful advances in visualizing, storing, processing, sharing, and moving data to enable bigger research projects and deeper discoveries. More than 4,000 international participants are expected to join the discussion at this year’s event.

“With pharma and biotech trading talent and everyone debating machine learning and artificial intelligence, there's never been a more important time to push past the hype and see what is really happening in the industry,” states Allison Proffitt, Editorial Director of Bio-IT World. “The biology behind sequencing, omics, and gene editing hurtles forward, and data are paramount. The 2018 Bio-IT World Expo plenary roster knows data science, both at pharma and biotech. Veterans of Merck, AstraZeneca, Novartis, and Johnson & Johnson bring decades of expertise to bear on the new challenges we've uncovered.”

View the full lineup of conference tracks, workshops and exhibit hall events at www.Bio-ITWorldExpo.com

Complimentary keynote and exhibit hall passes are available until May 4 at www.Bio-ITWorldExpo.com/Exhibit-Hall

Members of the media are encouraged to participate. Please contact Lisa Scimemi at lscimemi@healthtech.com to apply for a press pass and to inquire about opportunities for coordinated pre-event interviews with the speaking faculty.

About Bio-IT World (Bio-ITWorld.com)
Part of Healthtech Publishing, Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine. Through a variety of sources including, Bio-ITWorld.com, Weekly Update Newsletter and the Bio-IT World News Bulletins, Bio-IT World is a leading source of news and opinion on technology and strategic innovation in the life sciences, including drug discovery and development.

About Cambridge Healthtech Institute (healthtech.com)
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Preclinical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation, Bio-IT WorldClinical Informatics News and Diagnostics World.

Contact:

Lisa Scimemi
Cambridge Healthtech Institute
(781) 972-5446
lscimemi@healthtech.com